ESC Premium Access

Novel pharmacological therapy in chronic heart failure

Event: ESC CONGRESS 2016
Topic: Pharmacologic therapy
Session type: Moderated Posters
Date: 29 August 2016
Time: 10:05 - 10:55

Congress Session

7 presentations in this session

Contribution of central donepezil to prevention of cardiac dysfunction and improvement of long-term survival in chronic heart failure rats after myocardial infarction

Speaker: Doctor M. Li (Osaka, JP)

Stimulation of the soluble guanylate cyclase attenuates pressure-overload induced cardiac hypertrophy in mice

Speaker: Doctor J. Ruedebusch (Greifswald, DE)

Magnesium orotate improves symptoms, exercise capacity and quality of life in patients with valve prosthesis: results from a randomized, open-label, case-control 2-year study

Speaker: Professor I. Gaisin (Izhevsk, RU)

Effect of ipragliflozin, a sodium-glucose co-transporter 2 inhibitor, on diuresis and neurohormonal activation in type 2 diabetes mellitus and heart failure

Speaker: Doctor T. Takeuchi (Tsu, JP)

Get the right balance: a novel vasopressin receptor antagonist equally blocks human V1a and V2 receptors and inhibits the release of plasminogen activator inhibitor-1 from cardiomyocytes

Speaker: Doctor P. Kolkhof (Wuppertal, DE)

The CaMKII inhibitor RA123456 attenuates heart failure and prevents ventricular and atrial arrhythmias in vivo

Speaker: Mr J. Mustroph (Regensburg, DE)

The effects of LCZ696 on left ventricular remodeling in hypertensive patients - Results of a double blind, randomized, multicenter trial

Speaker: Professor R. Schmieder (Erlangen, DE)

7 speakers from this session

Doctor Meihua Li

National Cerebral and Cardiovascular Center Research Institute, Osaka (Japan)
0 follower

Doctor Julia Ruedebusch

Universitaetsmedizin Greifswald, Greifswald (Germany)
0 follower

Professor Ilshat Gaisin

State Medical Academy, Izhevsk (Russian Federation)
0 follower

Doctor Tetsushiro Takeuchi

Mie University Graduate School of Medicine, Tsu (Japan)
0 follower

Doctor Peter Kolkhof

BAYER HealthCare, Global Drug Discovery, Cardiology Research, Wuppertal (Germany)
0 follower

Mr Julian Mustroph

University Hospital Regensburg, Regensburg (Germany)
0 follower

Professor Roland Schmieder

University Hospital Erlangen, Department of Nephrology and Hypertension, Erlangen (Germany)
25 presentations
0 follower

This platform is supported by

logo Novo Nordisk